Why is Selectquote stock sliding today?
Selectquote (SLQT) shares dropped 16.59% in pre-market trading to $0.643 after missing Q4 2026 earnings and revenue estimates. The company reported a loss of $0.19 per share and $321.7M in revenue, while FY2027 guidance of $1.35B-$1.45B fell below consensus. Analysts had already lowered ratings due to sector headwinds, including Medicare Advantage marketing cuts and reimbursement pressures.
How this was made
The 30-second read
Why it matters
The earnings miss and weak guidance are likely to trigger short‑term price declines, with volatility spikes in the trading day.
Market read
Earnings surprise and guidance shortfall create immediate trading opportunity for SLQT; sector peers may be affected.
What to watch
Potential cost‑cutting measures and upcoming product initiatives not disclosed in the release.
Background
SelectQuote reported Q4 2026 results and FY2027 guidance, missing analyst expectations and prompting a sharp pre‑market sell‑off.
Ticker impact
Q4 2026 earnings miss and FY2027 revenue guidance below consensus triggered a 16.6% pre‑market drop.
Further downside pressure if guidance remains unchanged; potential bounce if management clarifies growth path.
The combination of a loss per share worse than estimates, revenue shortfall, and guidance $200M below consensus drives immediate sell pressure.
Market effects
Medicare insurance distribution sector faces headwinds from payer reimbursement pressure.
U.S. health‑insurance brokerage stocks may see broader weakness.
Limited to U.S. market; no direct global effect.
Counterpoint
If the company can secure new payer contracts, the stock may be oversold after the sharp drop.
Key entities
- companySelectQuote, Inc.
U.S. listed health‑insurance brokerage (ticker SLQT).
